5/14/2026 UPDATE: On May 14, 2026, the U.S. Supreme Court extended a stay preserving telehealth access to mifepristone while the Fifth Circuit considers a challenge to regulations permitting pharmacies, including mail‑order pharmacies, to dispense the drug directly to patients. The order maintains the existing regulatory framework for mifepristone, allowing prescribing via telehealth and dispensing... READ MORE
Fifth Circuit Court of Appeals Panel Grants Stay in Case Challenging FDA Regulation of Mifepristone
Posted on May 4, 2026 in Health Law News
Published by: Hall Render
